Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Meloxicam Patent Expiration

Meloxicam was first introduced by Boehringer Ingelheim Pharmaceuticals Inc in its drug Mobic on Apr 13, 2000. Other drugs containing Meloxicam are Anjeso, Qmiiz Odt, Vivlodex, Meloxicam. 30 different companies have introduced drugs containing Meloxicam.


Meloxicam Patents

Given below is the list of patents protecting Meloxicam, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Anjeso US10881663 Method of treating pain in elderly patients with mild renal impairment Mar 08, 2039 Baudax
Anjeso US11458145 Methods of administering intravenous meloxicam in a bolus dose Mar 08, 2039 Baudax
Vivlodex US9649318 Formulation of meloxicam Mar 31, 2035 Iceutica Operations
Vivlodex US9808468 Formulation of meloxicam Mar 31, 2035 Iceutica Operations
Vivlodex US9526734 Formulation of meloxicam Mar 31, 2033 Iceutica Operations
Qmiiz Odt US8545879 Fast disintegrating compositions of meloxicam Aug 31, 2030 Tersera
Anjeso US10709713 Nanoparticulate meloxicam formulations May 26, 2030 Baudax
Anjeso US11253478 Reduction of flake-like aggregation in nanoparticulate active agent compositions May 26, 2030 Baudax
Anjeso US9974746 Reduction of flake-like aggregation in nanoparticulate active agent compositions May 26, 2030 Baudax
Anjeso US10463673 Nanoparticulate meloxicam formulations Feb 24, 2024

(Expired)

 Baudax
Anjeso US10471067 Nanoparticulate meloxicam formulations Feb 24, 2024

(Expired)

 Baudax
Anjeso US8512727 Nanoparticulate meloxicam formulations Dec 25, 2022

(Expired)

 Baudax
Meloxicam US6184220

(Pediatric)

 Oral suspension of pharmaceutical substance Sep 25, 2019

(Expired)

 Avondale Pharms
Meloxicam US6184220 Oral suspension of pharmaceutical substance Mar 25, 2019

(Expired)

 Avondale Pharms



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Meloxicam's patents.

Given below is the list recent legal activities going on the following patents of Meloxicam.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Yr, Small Entity 07 May, 2021 US9808468
Payment of Maintenance Fee, 8th Year, Large Entity 17 Mar, 2021 US8545879
Payment of Maintenance Fee, 4th Yr, Small Entity 16 Nov, 2020 US9649318
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 16 Oct, 2020 US9649318
Payment of Maintenance Fee, 4th Yr, Small Entity 29 Jun, 2020 US9526734
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 22 May, 2020 US9526734
Patent Issue Date Used in PTA Calculation
Critical
 07 Nov, 2017 US9808468
Recordation of Patent Grant Mailed
Critical
 07 Nov, 2017 US9808468
Email Notification
Critical
 19 Oct, 2017 US9808468
Issue Notification Mailed
Critical
 18 Oct, 2017 US9808468


Meloxicam's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Meloxicam Generic API Manufacturers

Several generic applications have been filed for Meloxicam. The first generic version for Meloxicam was by Roxane Laboratories Inc and was approved on Jul 19, 2006. And the latest generic version is by Ascent Pharmaceuticals Inc and was approved on Jun 7, 2023.

Given below is the list of companies who have filed for Meloxicam generic, along with the locations of their manufacturing plants worldwide.


1. AIPING PHARM INC

Aiping Pharmaceutical Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Aiping Pharm Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG

tablet Prescription ORAL AB Jul 19, 2006
15MG

tablet Prescription ORAL AB Jul 19, 2006





2. ANDA REPOSITORY

Anda Repository Llc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Anda Repository.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG

tablet Discontinued ORAL N/A Jul 19, 2006
15MG

tablet Discontinued ORAL N/A Jul 19, 2006





3. ASCENT PHARMS INC

Ascent Pharmaceuticals Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG

tablet Prescription ORAL AB Jun 7, 2023
7.5MG

tablet Prescription ORAL AB Jun 7, 2023





4. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG

tablet Prescription ORAL AB Oct 2, 2006
15MG

tablet Prescription ORAL AB Oct 2, 2006


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Bachupally Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
Sangareddy Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





5. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG

tablet Discontinued ORAL N/A Jul 19, 2006
15MG

tablet Discontinued ORAL N/A Jul 19, 2006





6. CIPLA

Cipla Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG

tablet Prescription ORAL AB Jul 19, 2006
15MG

tablet Prescription ORAL AB Jul 19, 2006


Manufacturing Plant Locations
New

Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.

Country City Firm Name
India
Bangalore Cipla Ltd.
Vasco Da Gama Cipla Limited
Kurkumbh Village, Dist. Pune Cipla, Ltd.
Pithampur, District Dhar Cipla Limited
Bengaluru Cipla Limited
Raigad Cipla Limited
Mumbai Cipla Limited





7. COREPHARMA

Corepharma Llc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Corepharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG

tablet Prescription ORAL AB Jul 20, 2006
7.5MG

tablet Prescription ORAL AB Jul 20, 2006


Manufacturing Plant Locations
New

Corepharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Corepharma as present at those locations.

Country City Firm Name
United States
Middlesex CorePharma, LLC





8. CR DOUBLE CRANE

China Resources Double Crane Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Cr Double Crane.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG

tablet Discontinued ORAL N/A Dec 14, 2006
7.5MG

tablet Discontinued ORAL N/A Dec 14, 2006





9. DR REDDYS LABS INC

Dr Reddys Laboratories Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG

tablet Prescription ORAL AB Jul 25, 2006
7.5MG

tablet Prescription ORAL AB Jul 25, 2006





10. ESJAY PHARMA

Esjay Pharma Llc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Esjay Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG

tablet Prescription ORAL AB May 13, 2009
7.5MG

tablet Prescription ORAL AB May 13, 2009





11. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG

tablet Prescription ORAL AB Jul 19, 2006
15MG

tablet Prescription ORAL AB Jul 19, 2006





12. IMPAX LABS INC

Impax Laboratories Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG

tablet Discontinued ORAL N/A Jul 19, 2006
15MG

tablet Discontinued ORAL N/A Jul 19, 2006





13. LUPIN LTD

Lupin Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

capsule Prescription ORAL AB Jun 1, 2020
10MG

(reference standard)

capsule Prescription ORAL AB Jun 1, 2020


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.





14. LUPIN PHARMS

Lupin Pharmaceuticals Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Lupin Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG

tablet Prescription ORAL AB Jul 19, 2006
15MG

tablet Prescription ORAL AB Jul 19, 2006





15. MYLAN

Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG

tablet Discontinued ORAL N/A Jul 20, 2006
15MG

tablet Discontinued ORAL N/A Jul 20, 2006


Manufacturing Plant Locations
New

Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.

Country City Firm Name
United States
Santa Barbara Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
San Carlos Mylan Pharmaceuticals Inc.
Saint Albans Mylan Technologies, Inc.
Morgantown Mylan Specialty, L.P.
Greensboro Mylan Pharmaceuticals Inc
Morgantown MYLAN CONSUMER HEALTHCARE Inc.
Rockford Mylan Institutional, Inc.
India
Anekal Taluk, Bangalore Mylan Laboratories Limited
Sinnar Mylan Laboratories Limited
Hosur Mylan Laboratories Limited
Hyderabad Mylan Laboratories Limited
Bangalore Mylan Laboratories Limited
Sarigam Mylan Laboratories Limited
Aurangabad Mylan Laboratories Limited (FDF-2)
Pithampur, District Dhar Mylan Laboratories Limited
Canada
Etobicoke Mylan Pharmaceuticals ULC
Ireland
Inverin Mylan Teoranta





16. NATCO PHARMA

Natco Pharma Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Natco Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG

tablet Discontinued ORAL N/A Jul 19, 2006
15MG

tablet Discontinued ORAL N/A Jul 19, 2006


Manufacturing Plant Locations
New

Natco Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Natco Pharma as present at those locations.

Country City Firm Name
India
Paravada Natco Pharma Limited
Hyderabad Natco Pharma Limited
Rangareddy NATCO Pharma Limited
Rangareddy District Natco Pharma Ltd. - Chemical Division
Hyderabad NATCO PHARMA LTD
Chennai NATCO Pharma Limited Chemical Division Chennai





17. NOVITIUM PHARMA

Novitium Pharma Llc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Novitium Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

capsule Prescription ORAL AB Mar 9, 2021
5MG

capsule Prescription ORAL AB Mar 9, 2021


Manufacturing Plant Locations
New

Novitium Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Novitium Pharma as present at those locations.

Country City Firm Name
United States
East Windsor Novitium Pharma LLC





18. PURACAP PHARM

Puracap Pharmaceutical Llc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Puracap Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG

tablet Prescription ORAL AB Jul 19, 2006
15MG

tablet Prescription ORAL AB Jul 19, 2006





19. ROXANE

Roxane Laboratories Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Roxane.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG

tablet Discontinued ORAL N/A Jul 19, 2006
7.5MG

tablet Discontinued ORAL N/A Jul 19, 2006





20. SUN PHARM INDS INC

Sun Pharmaceutical Industries Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG

tablet Discontinued ORAL N/A Jul 19, 2006
15MG

tablet Discontinued ORAL N/A Jul 19, 2006





21. TARO

Taro Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG

tablet Prescription ORAL AB Nov 7, 2006
7.5MG

tablet Prescription ORAL AB Nov 7, 2006


Manufacturing Plant Locations
New

Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.

Country City Firm Name
United States
Honolulu Taro Delight, LLC
Hawthorne Taro Pharmaceuticals U.S.A., Inc.
Israel
Haifa Taro Pharmaceutical Industries, Ltd.
Canada
Brampton Taro Pharmaceuticals Inc.





22. UNICHEM

Unichem Laboratories Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Unichem.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG

tablet Prescription ORAL AB Dec 20, 2006
7.5MG

tablet Prescription ORAL AB Dec 20, 2006


Manufacturing Plant Locations
New

Unichem's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Unichem as present at those locations.

Country City Firm Name
India
District Raigad Unichem Laboratories Ltd
Mumbai Unichem Laboratories Limited
Pithampur Unichem Laboratories Limited
Kolhapur Unichem Laboratories Limited
Ghaziabad Unichem Laboratories Ltd.
Pilerne Bardez Unichem Laboratories Limited
United States
East Brunswick Unichem Pharmaceuticals USA Inc.
Hasbrouck Heights Unichem Pharmaceuticals Usa Inc





23. YABAO PHARM

Yabao Pharmaceutical Co Ltd Beijing has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Yabao Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG

tablet Discontinued ORAL N/A Jul 19, 2006
15MG

tablet Discontinued ORAL N/A Jul 19, 2006


Manufacturing Plant Locations
New

Yabao Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Yabao Pharm as present at those locations.

Country City Firm Name
China
Tongzhou Yabao Pharmaceutical Co., Ltd. Beijing
Yuncheng Yabao Pharmaceutical Group Co., Ltd





24. YUNG SHIN PHARM

Yung Shin Pharmaceutical Industrial Co Ltd has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Yung Shin Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG

tablet Prescription ORAL AB Dec 7, 2006
7.5MG

tablet Prescription ORAL AB Dec 7, 2006


Manufacturing Plant Locations
New

Yung Shin Pharm's manufacturing plants are situated in 2 countries - China, Taiwan. Given below are the details of these plant locations as well as the firm names of Yung Shin Pharm as present at those locations.

Country City Firm Name
China
Kunshan Yung Shin Pharmaceutical Industrial (Kunshan) Co., Ltd.
Taiwan
Taichung City Yung Shin Pharmaceutical Industry Co., Ltd.





25. ZYDUS PHARMS USA

Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Meloxicam. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG

tablet Prescription ORAL AB Jul 19, 2006
15MG

(reference standard)

tablet Prescription ORAL AB Jul 19, 2006